How blood cancer treatment is evolving in the Middle East Artwork

The Pharma Letter Podcast

The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.

All Episodes

The Pharma Letter Podcast

How blood cancer treatment is evolving in the Middle East

December 08, 2025 • Simon Wentworth • Season 1 • Episode 36

This week on the Podcast, we are joined by Dr Amr Hanbali.

During Blood Cancer Awareness Month, Guy Martin, news editor at The Pharma Letter, sat down with Dr Hanbali to discuss his experiences treating patients with CAR T-cell therapy in the Middle East.

With extensive experience in hematology and the treatment of blood disorders such as leukemia and myeloma, Dr Hanbali has been closely involved in expanding access to advanced therapies across Saudi Arabia and the wider region.

Dr Hanbali discussed the evolution of blood cancer treatment in the Middle East, the unique challenges patients face in accessing cutting-edge therapies, and how CAR T-cell treatments are offering renewed hope for long-term remission.

He also shared his personal reflections on the impact of this therapy on patients and families, what needs to happen to improve regional access, and his vision for the future of blood cancer care in the next decade.

Simon Wentworth

Host